Perceptive Advisors’s Derma Sciences, Inc. Common Stock (DE) DSCI Stock Holding History

Perceptive Advisors’s Portfolio DSCI Stock Details DSCI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-2,970	Closed	-$14K	–	242
2016 Q3	$14K	Sell	2,970 -429,914	-99%	-$2.01M	﹤0.01%	181
2016 Q2	$1.71M	Hold	432,884	–	–	0.12%	89
2016 Q1	$1.34M	Buy	432,884 +30,000	+7%	+$100K	0.12%	96
2015 Q4	$1.84M	Buy	402,884 +42,300	+12%	+$201K	0.14%	76
2015 Q3	$1.7M	Buy	360,584 +11,800	+3%	+$76.2K	0.14%	85
2015 Q2	$25M	Buy	348,784 +5,500	+2%	+$41.4K	1.51%	14
2015 Q1	$2.91M	Buy	343,284 +29,701	+9%	+$253K	0.23%	74
2014 Q4	$2.92M	Buy	313,583 +97,774	+45%	+$850K	0.24%	73
2014 Q3	$1.8M	Sell	215,809 -190,628	-47%	-$1.77M	0.18%	72
2014 Q2	$4.7M	Sell	406,437 -126,363	-24%	-$1.3M	0.46%	45
2014 Q1	$6.76M	Buy	+532,800	New	+$6.89M	0.71%	38

Other funds holding DSCI

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

GIM

Granahan Investment Management Waltham, Massachusetts $2.81B AUM 83.9% 1-Year Est. Return

KAM

Krensavage Asset Management New York $263M AUM 66.99% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Manulife (Manufacturers Life Insurance) Canada, Ontario, Canada $128B AUM 35.83% 1-Year Est. Return

Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return

Perceptive Advisors's DSCI Position: Q4 2016 in Review

Perceptive Advisors sold out of Derma Sciences, Inc. Common Stock (DE) (DSCI) in Q4 2016, closing a stake of 2,970 shares — an estimated $14K sold.

Perceptive Advisors first reported a position in DSCI in Q1 2014 and held it in 11 quarters. The position peaked at $25M in Q2 2015. 52 funds tracked by Wall St. Rank hold DSCI as of Q4 2016.

Perceptive Advisors reported no remaining Derma Sciences, Inc. Common Stock (DE) position as of Q4 2016 after selling out during the quarter.
Perceptive Advisors sold 2,970 Derma Sciences, Inc. Common Stock (DE) shares in Q4 2016, an estimated $14K.
Perceptive Advisors first reported a position in Derma Sciences, Inc. Common Stock (DE) in Q1 2014 and held it in 11 quarters.
Perceptive Advisors's Derma Sciences, Inc. Common Stock (DE) position peaked at $25M in Q2 2015.
52 funds tracked by Wall St. Rank held Derma Sciences, Inc. Common Stock (DE) as of Q4 2016.

Based on Perceptive Advisors's 13F filing for Q4 2016, filed 14 Feb 2017.